Julie Sinnamon, CEO Enterprise Ireland said, “This is a hugely significant and very welcome development for GII and the region. Enterprise Ireland has worked closely with the company in this current major expansionary phase and looks forward to continuing to support GII and the industry, which forms a vital part of the Irish economy”.
GII first launched its range of advanced milk protein powders under the Solmiko brand in 2008 and has since had much success with their application in the clinical nutrition and sports nutrition industries, making it one of the leading suppliers of milk proteins globally. These industries are worth €16 billion and are currently growing at greater than 6% per annum. The new SolmikoHD and SolagoHD variants have higher bulk density and good dispersibility making them easily incorporated into customer formulations using existing processing equipment.
The new facility in Virginia reinforces GII’s credentials on sustainability and conservation, and uses additional membrane technology that polishes and removes all remaining solids from the water extracted from the process, making it re-usable so no additional water is required for the new plant.